Arcadia Biosciences, Inc. (RKDA) NASDAQ
1.35
+0.05(+3.85%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.35
+0.05(+3.85%)
Currency In USD
| Previous Close | 1.3 |
| Open | 1.34 |
| Day High | 1.37 |
| Day Low | 1.32 |
| 52-Week High | 6.71 |
| 52-Week Low | 1.3 |
| Volume | 3,111 |
| Average Volume | 32,446 |
| Market Cap | 1.85M |
| PE | -0.79 |
| EPS | -1.71 |
| Moving Average 50 Days | 1.81 |
| Moving Average 200 Days | 3.28 |
| Change | 0.05 |
Arcadia Biosciences (RKDA) Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds
GlobeNewswire Inc.
Jan 12, 2026 1:00 PM GMT
DALLAS, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that it has entered into definitive agreements for the immediate exercise of certain outs
Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources
GlobeNewswire Inc.
Dec 26, 2025 1:02 PM GMT
DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that on December 24, 2025, it received a notice from Roosevelt Resources, LP, terminating
Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights
GlobeNewswire Inc.
Nov 07, 2025 9:05 PM GMT
-- Zola® year-to-date revenues increase 26% year over year ---- Arcadia gross profit margins exceed 30% for 11th straight quarter ---- Arcadia cash balance declines by only $257K to $1.1M -- DALLAS, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosci